Abstract
Background
Postoperative facial scarring can be a significant psychological burden for patients to carry after surgery, often resulting in prolonged mental health dysfunction. Currently, there is no established method to prevent facial scar formation; however, there are several methods to prevent facial scar hyperplasia and improve scar quality. Botulinum toxin A (BTA) has been widely used due to its properties of muscle paralysis and known success in plastic surgery and cosmetology. This meta-analysis aimed to evaluate the efficacy of BTA in preventing postoperative facial scar hyperplasia and improving scar quality.
Methods
PubMed, MEDLINE, EMBASE, web of science, and Cochrane libraries were searched for randomized controlled trials (RCTs) (published before May 2021) wherein BTA was used for the treatment of facial scars. The efficacy and safety of BTA were evaluated by the following scales: the Vancouver Scar Scale (VSS), Visual Analog Scale (VAS), Observer Scar Assessment Scale (OSAS), Patient Scar Assessment Scale (PSAS), and Stony Brook Scar Evaluation Scale (SBSES); the BTA effect on scar width and complications was also assessed.
Results
Ten RCTs involving 114 cases were included. Through quantitative analysis, the BTA injection group had a higher VAS score, lower VSS score, lower OSAS score, and smaller scar width. However, no significant difference was noted in the incidence of postoperative complications between the two groups.
Conclusions
This meta-analysis demonstrated that BTA can safely improve the appearance of postoperative facial scars by significantly inhibiting scar hyperplasia and improving scar quality.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
Reference
Kim SH, Lee SJ, Lee JW, Jeong HS, Suh IS (2019) Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: a double-blinded, randomized controlled study. Med (Baltimore) 98(34):e16952
Tebble NJ, Thomas DW, Price P (2004) Anxiety and self-consciousness in patients with minor facial lacerations. J Adv Nurs 47(4):417–426
Jeong HS et al (2015) Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue. Plast Reconstr Surg 136(2):171e–178e
Sherris DA, Larrabee WF Jr, Murakami CS (1995) Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 28(5):1057–1068
Chowdhury B et al (2021) Laser in surgical scar clearance: an update review. J Cosmet Dermatol. https://doi.org/10.1111/jocd.14325,July2,2021
Xiao Z, Zhang F, Cui Z (2009) Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthetic Plast Surg 33(3):409–412
Xiao Z, Zhang F, Lin W, Zhang M, Liu Y (2010) Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report. Aesthetic Plast Surg 34(4):424–427
Ibrahim O, Keller EC, Arndt KA (2014) Update on botulinum neurotoxin use in aesthetic dermatology. Semin Cutan Med Surg 33(4):152–156
Scott AB, Rosenbaum A, Collins CC (1973) Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12(12):924–927
Cocco A, Albanese A (2018) Recent developments in clinical trials of botulinum neurotoxins. Toxicon 147(1):77–83
Sherris DA, Gassner HG (2002) Botulinum toxin to minimize facial scarring. Facial Plast Surg 18(1):35–39
Lu L et al (2005) The temporal effects of anti-TGF-β1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201(3):391–397
Reid RR, Roy N, Mogford JE, Zimmerman H, Lee C, Mustoe TA (2007) Reduction of hypertrophic scar via retroviral delivery of a dominant negative TGF-beta receptor II. J Plast Reconstr Aesthet Surg 60(1):64–72
Gassner HG, Sherris DA, Otley CC (2000) Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg 105(6):1948–1953
Li YH et al (2018) A randomized, placebo-controlled, double-blind, prospective clinical trial of botulinum toxin type A in prevention of hypertrophic scar development in median sternotomy wound. Aesthetic Plast Surg 42(5):1364–1369
Abedini R, Mehdizade Rayeni N, Haddady Abianeh S, Rahmati J, Teymourpour A, Nasimi M (2020) Botulinum toxin type A injection for mammoplasty and abdominoplasty scar management: A split-scar double-blinded randomized controlled study. Aesthetic Plast Surg 44(6):2270–2276
Elshahed AR, Elmanzalawy KS, Shehata H, ElSaie ML (2020) Effect of botulinum toxin type A for treating hypertrophic scars: a split-scar, double-blind randomized controlled trial. J Cosmet Dermatol 19(9):2252–2258
Moher D et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1
Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK (2014) Botulinum toxin to improve results in cleft lip repair. Plast Reconstr Surg 134(3):511–516
Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PK (2014) Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial. PLoS ONE 9(12):e115690
Gassner HG et al (2006) Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 81(8):1023–1028
Hu L et al (2018) Effects of botulinum toxin on improving facial surgical scars: a prospective, split-scar, double-blind, randomized controlled trial. Plast Reconstr Surg 141(3):646–650
Huang RL, Ho CK, Tremp M, Xie Y, Li Q, Zan T (2019) Early postoperative application of botulinum toxin type a prevents hypertrophic scarring after epicanthoplasty: a split-face, double-blind, randomized trial. Plast Reconstr Surg 144(4):835–844
Lee SH, Min HJ, Kim YW, Cheon YW (2018) The efficacy and safety of early postoperative botulinum toxin A injection for facial scars. Aesthetic Plast Surg 42(2):530–537
Navarro-Barquín DF et al (2019) Use of the type A botulinum toxin in patients submitted to cheiloplasty to improve results in scarring in patients with nonsyndromic cleft lip and palate. Eur J Plast Surg 42(3):291–294
Zelken J et al (2016) Donor site aesthetic enhancement with preoperative botulinum toxin in forehead flap nasal reconstruction. Ann Plast Surg 77(5):535–538
Ziade M et al (2013) Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study. J Plast Reconstr Aesthet Surg 66(2):209–214
Sung YT, Wu JS (2018) The visual analogue scale for rating, ranking and paired-comparison (VAS-RRP): a new technique for psychological measurement. Behav Res Methods 50(4):1694–1715
Thompson CM, Sood RF, Honari S, Carrougher GJ, Gibran NS (2015) What score on the vancouver scar scale constitutes a hypertrophic scar? results from a survey of north American burn-care providers. Burns 41(7):1442–1448
Refahee SM et al (2020) Is PRP effective in reducing the scar width of primary cleft lip repair? A randomized controlled clinical study. Cleft Palate Craniofac J 57(5):581–588
Prodromidou A et al (2015) Botulinum toxin for the prevention and healing of wound scars: a systematic review of the literature. Plast Surg (Oakv) 23(4):260–264
Burns JL, Mancoll JS, Phillips LG (2003) Impairments to wound healing. Clin Plast Surg 30(1):47–56
Bae DS, Koo DH, Kim JE, Cho JM, Park JO (2020) Effect of botulinum toxin A on scar healing after thyroidectomy: a prospective double-blind randomized controlled trial. J Clin Med 9(3):868
Bellows S, Jankovic J (2019) Immunogenicity associated with botulinum toxin treatment. Toxins (Basel) 11(9):1–22
Castelão M et al (2017) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 12(12):cd003633
Small R (2014) Botulinum toxin injection for facial wrinkles. Am Fam Physician 90(3):168–175
Xiao Z, Qu G (2012) Effects of botulinum toxin type a on collagen deposition in hypertrophic scars. Molecules 17(2):2169–2177
Suarez E, Syed F, Rasgado TA, Walmsley A, Mandal P, Bayat A (2014) Skin equivalent tensional force alters keloid fibroblast behavior and phenotype. Wound Repair Regen 22(5):557–568
Suarez E, Syed F, Alonso-Rasgado T, Mandal P, Bayat A (2013) Up-regulation of tension-related proteins in keloids: knockdown of Hsp27, α2β1-integrin, and PAI-2 shows convincing reduction of extracellular matrix production. Plast Reconstr Surg 131(2):158e–173e
Qiao Z, Yang H, Jin L, Li S, Wang X (2021) The efficacy and safety of botulinum toxin injections in preventing postoperative scars and improving scar quality: a systematic review and meta-analysis. Aesthetic Plast Surg. https://doi.org/10.1007/s00266-021-02196-5,March5,2021
Lee BJ, Jeong JH, Wang SG, Lee JC, Goh EK, Kim HW (2009) Effect of botulinum toxin type a on a rat surgical wound model. Clin Exp Otorhinolaryngol 2(1):20–27
Ortonne JP, Bissett DL (2008) Latest insights into skin hyperpigmentation. J Investig Dermatol Symp Proc 13(1):10–14
Vercelli S, Ferriero G, Sartorio F, Stissi V, Franchignoni F (2009) How to assess postsurgical scars: a review of outcome measures. Disabil Rehabil 31(25):2055–2063
Duncan JAL et al (2006) Visual analogue scale scoring and ranking: a suitable and sensitive method for assessing scar quality? Plast Reconstr Surg 118(4):909–918
Bae SH, Bae YC (2014) Analysis of frequency of use of different scar assessment scales based on the scar condition and treatment method. Arch Plast Surg 41(2):111–115
Nguyen DQ, Potokar T, Price P (2008) A review of current objective and subjective scar assessment tools. J Wound Care 17(3):101–106
Stavrou D, Haik J, Weissman O, Goldan O, Tessone A, Winkler E (2009) Patient and observer scar assessment scale: how good is it? J Wound Care 18(4):171–176
Singer AJ, Arora B, Dagum A, Valentine S, Hollander JE (2007) Development and validation of a novel scar evaluation scale. Plast Reconstr Surg 120(7):1892–1897
Brodsky MA, Swope DM, Grimes D (2021) Diffusion of botulinum toxins. Tremor Other Hyperkinet Mov. https://doi.org/10.7916/D88W3C1M,August2,2021
Chen Z et al (2021) The effect of botulinum toxin injection dose on the appearance of surgical scar. Sci Rep 11(1):13670
Gugerell A, Kober J, Schmid M, Buchberger E, Kamola LP, Keck M (2016) Botulinum toxin A: dose-dependent effect on reepithelialization and angiogenesis. Plast Reconstr Surg Glob Open 4(8):e837
Kim YS, Lee HJ, Cho SH, Lee JD, Kim HS (2014) Early postoperative treatment of thyroidectomy scars using botulinum toxin: A split-scar, double-blind randomized controlled trial. Wound Repair Regen 22(5):605–612
Funding
The authors have nothing to disclose.
The named authors have no commercial interest and financial or material support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yue, S., Ju, M. & Su, Z. A Systematic Review And Meta-Analysis: Botulinum Toxin A Effect on Postoperative Facial Scar Prevention. Aesth Plast Surg 46, 395–405 (2022). https://doi.org/10.1007/s00266-021-02596-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-021-02596-7